Uitgebreid zoeken

Fred B. Rothman richtte Paramount Residential Mortgage Group, Inc. op. Op dit moment is de heer Rothman Chief Operating Officer voor Lennar Corp. In zijn vorige loopbaan was de heer Rothman Senior Manager-Project bij Toll Brothers, Inc., Founding Partner van Sgs Communities, Inc., President-New Jersey Division bij D.R. Horton, Inc., Corporate Attorney bij Kronish, Lieb, Weiner, & Hellman LLP en Vice President-Development & Acquisition bij Calton Homes, Inc. Fred B. Rothman behaalde zijn doctoraal aan de Universiteit van Pennsylvania en zijn doctoraal aan de New York University School of Law.

Marc Rothman bekleedt de functie van Chief Medical Officer bij Signify Health, Inc. Dr. Rothman is tevens lid van de American Medical Directors Association en lid van The American Geriatrics Society, Inc. Dr. Rothman was voorheen Deputy Chief Medical Officer bij Aspire Healthcare Ltd., Chief Medical Officer & Senior Vice President voor Kindred Healthcare LLC, Lid van de American Society of Internal Medicine en Lid van het American College of Physicians, Inc. Dr. Rothman behaalde een doctoraat aan de New York University School of Medicine en een doctoraat aan de University of Wisconsin.

Lynn Rothman is Chief Business Officer & Executive VP bij Penumbra, Inc. en Co-Managing Director bij Penumbra Europe GmbH (een dochteronderneming van Penumbra, Inc.). In haar vorige carrière bekleedde mevrouw Rothman de functie van Principal bij Robertson Stephens & Co. en Marketing Director bij Confer Software, Inc. Mevrouw Rothman behaalde een bachelorgraad aan de Stanford University en een MBA aan The Wharton School van de Universiteit van Pennsylvania.

Fred Huang, de oprichter van Pacgen Life Science Corp., is een zakenman die aan het hoofd heeft gestaan van 5 verschillende bedrijven en in de raad van bestuur van Pacgen Life Science Corp. zit. In het verleden was hij Chief Executive Officer voor Elitecell Biomedical Corp., President voor Asian Enterprises, Inc., President bij China Steel Corp., President bij Klckner & Co. SE, Chief Operating Officer voor Aventacell Biomedical Co., Ltd., Chief Financial Officer voor Cytocan Biotechnology, Inc. en Chief Executive Officer van Gworei Biomedical Technology Co., Ltd. Hij behaalde een bachelordiploma aan de National Taipei University of Technology en een MBA aan de USC Marshall School of Business.

Fred Hand bekleedt de functie van Chief Executive Officer & Director bij Tuesday Morning Corp. De heer Hand is tevens Executive Vice President-Stores bij Burlington Coat Factory Warehouse Corp. en Executive Vice President-Stores bij Burlington Coat Factory Investments Holdings, Inc. In zijn vorige carrière was hij Chief Operating Officer & Principal bij Burlington Stores, Inc., Senior Vice President & Group Director-Stores bij Macy's, Inc. en Regional Vice President bij The May Department Stores Co. (een dochteronderneming van Macy's, Inc.) en Senior VP-Stores & Visual Merchandising bij Filene's Basement Corp.

Fred W. Boehler is President, Chief Executive Officer & Trustee bij Americold Realty Trust, Inc. en President & Chief Executive Officer van Americold Realty, Inc. en President, Chief Executive Officer & Trustee bij Americold Logistics LLC (beide zijn dochtermaatschappijen van Americold Realty Trust, Inc.). Daarvoor was hij Senior Vice President Logistics & Purchasing bij Borders Group, Inc. en Senior Vice President-Supply Chain bij SUPERVALU, Inc. De heer Boehler behaalde een diploma aan de Northern Illinois University en een diploma aan de Wright State University (Ohio).

Fred Faching Chang richtte ABS Computer Technologies, Inc. en Newegg, Inc. op. De heer Chang is lid van de raad van bestuur van Newegg Commerce, Inc. Voorheen bekleedde de heer Chang de functie van Chief Executive Officer van ABS Computer Technologies, Inc. en voorzitter van Newegg, Inc. Hij behaalde een bachelorgraad aan de Chinese Cultuuruniversiteit.

De heer Fred Mason is Vice President-Operations bij Mahdia Gold Corp. en Vice President-Operations bij Prodigy Gold, Inc. De heer Mason was voorheen werkzaam als Vice President-Operations bij Shear Diamonds Ltd., Vice President-Operations bij Starfield Resources, Inc., Construction Manager bij New Gold, Inc., General Manager-Pascua Lama Project bij Barrick Gold Corp., General Manager-Toquepala Area bij Southern Peru Copper Corp., Vice President & General Manager-Refugio Project bij Kinross Gold Corp., en VP-Operations & Senior Mining Manager bij Freeport-McMoRan, Inc. Hij behaalde zijn doctorale graad aan de Universiteit van Saskatchewan.

Op dit moment is Fred Killeen Chief Information Officer van General Motors Co.

Mr. Fred Jensen is Chief Compliance Officer bij Western Asset Diversified Income Fund, Chief Compliance Officer bij Clearbridge MLP & Midstream Fund, Inc., Chief Compliance Officer bij ClearBridge MLP & Midstream Total Return Fund, Inc., Chief Compliance Officer bij Western Asset Global Corporate Defined Opportunity Fund, Inc, een Chief Compliance Officer bij Western Asset Global High Income Fund, Inc., een Chief Compliance Officer bij Western Asset High Income Fund II, Inc., een Chief Compliance Officer bij Western Asset Investment Grade Defined Opportunity Tr, Inc., een Chief Compliance Officer bij Western Asset Municipal Defined Opportunity Trust, Inc, een Chief Compliance Officer bij ClearBridge Energy Midstream Opportunity Fund, Inc., een Chief Compliance Officer bij LMP Capital & Income Fund, Inc., een Chief Compliance Officer bij Western Asset High Income Opportunity Fund, Inc., een Chief Compliance Officer bij Western Asset Mortgage Opportunity Fund, Inc, een Chief Compliance Officer bij Western Asset Municipal Partners Fund, Inc., een Director-Global Compliance bij Franklin Resources, Inc., een Chief Compliance Officer bij Western Asset Managed Municipals Fund, Inc., een Chief Compliance Officer bij BrandywineGLOBAL - Global Income Opportunities Fund, Inc. en een Chief Compliance Officer bij Western Asset Emerging Markets Debt Fund, Inc. Dhr. Jensen was voordien werkzaam als Managing Director bij Legg Mason & Co. LLC (New York), Chief Compliance Officer bij Ambac Financial Group, Inc., Chief Compliance Officer bij Legg Mason Private Portfolio Group LLC, en Chief Compliance Officer bij Legg Mason Global Asset Allocation LLC.

Fred H. Langhammer is lid van de Raad van Bestuur van het American Institute for Contemporary German Studies, RWL Water LLC en D8 Holdings Corp. en Voorzitter-Global Affairs bij The Este Lauder Companies, Inc. en lid van The Trilateral Commission. In zijn vorige loopbaan bekleedde de heer Langhammer de functie van Senior Advisor bij Centerview Partners Holdings LLC.

Momenteel is Fred Swanepoel Chief Information Officer bij Nedbank Group Ltd. Hij behaalde zijn doctoraal aan de Universiteit van Stellenbosch en een MBA aan de Wits Business School.

De heer Fred Ehrsam is een Co-Managing Partner bij Paradigm Operations LP. Hij zit in de Raad van Bestuur van Fireblocks, Inc., Coinbase, Inc. en Coinbase Global, Inc. De heer Ehrsam was voorheen werkzaam als Head-Portfolio Analytics bij BlackRock, Inc. en als Trader-Securities Division bij Goldman Sachs & Co. LLC. Hij behaalde zijn doctoraal aan de Duke University.

De heer Fred Grnwall is Directeur-Technische Operaties bij Fabege AB.

Fred Knight is currently the Chief Compliance Officer at Eargo, Inc. Prior to this, he held positions as Senior Director-Ethics & Compliance at McKesson Corp., Vice President-Compliance, Ethics & Legal at Centene Corp., and Chief Compliance Officer & Senior Vice President at AltaMed Health Services Corp.
He received his undergraduate degree from Alabama A&M University and his MBA from Jacksonville University.

Mr. Mike Rothman is a Senior Associate at Ares Management LLC.
He joined Ares in June 2011 in the Private Debt Group and serves as a Senior Associate.
Prior to Ares, he worked at EIG Global Energy Partners for 3 years as an Assistant Vice President where he evaluated, structured and executed mezzanine debt transactions in the power generation sector.
He began his career at JPMorgan – initially supporting the Investment Bank’s chief credit executive covering the Real Estate, Lodging and Gaming sectors, and more recently in the Structured Finance CLO Group where he oversaw the bank's warehouse credit book exposure and helped manage over $9 billion in high yield securities.
Mr. Rothman received a BS in Applied Economics and Management from Cornell University.

Joel M.
Rothman is currently the Chief Development Officer at Equillium, Inc. He previously worked as the Director-Regional Operations at ICON Clinical Research, Inc. from 1998 to 2004, Vice President at Cytokinetics, Inc. from 2017 to 2018, Vice President-Development Operations at Jazz Pharmaceuticals, Inc., and Vice President at Raptor Pharmaceuticals, Inc. from 2015 to 2017.
Rothman received his undergraduate degree from Albright College and his graduate degree from Massachusetts Institute of Technology.

Marsha W.
Rothman has a career history that includes being a Trustee at The Philadelphia Museum of Art since 2014.

Claire L.
Rothman is currently an Honorary Director at City of Hope National Cancer Institute.

Omri Rothman is currently a Director at Supplant Agro-Project Ltd.
and Gling Consulting Ltd.
He was previously the Chief Executive Officer & Director at Smart Agro LP from 2020 to 2021.
He has also held positions as a Director at PCB Technologies Ltd., Elgo Irrigation Ltd., Orian Sh.M.
Ltd., and as the Chief Financial Officer & Vice President at Challenge Partners.
Additionally, he was the Chief Financial Officer at Kaiima Bio Agritech Ltd.
Mr. Rothman received an undergraduate degree from the University of Haifa.

Patricia Rothman is a Trustee of National Maritime Museum.

Founder of ARIAD Pharmaceuticals, Inc., James E.
Rothman presently is Senior Advisor at Arsenal Capital Management LP.
Dr. Rothman is also on the board of TractManager, Inc., Optimvia LLC and WCG Clinical, Inc. and Professor & Director-Nanobiology Institute at Yale School of Medicine.
In the past Dr. Rothman occupied the position of Advisor at Johnson & Johnson, Consultant at Eli Lilly & Co., Consultant at GlaxoSmithKline (New Jersey), Strategic Advisor at The Courtagen Group LLC, Chief Scientist at General Electric Healthcare Technologies, Inc., Consultant at Genentech, Inc., Advisor at GE Healthcare Ltd.
(United Kingdom), Professor & Director-Sulzberger Genome at The Trustees of Columbia University in The City of New York, Professor at Stanford University, Professor at Princeton University and Vice Chairman & Chairman-Cellular Biochemistry at Memorial Sloan Kettering Cancer Center.
James E.
Rothman received a doctorate from Harvard University and an undergraduate degree from Yale University.

Irving H.
Rothman served as President & CEO at Hewlett-Packard Financial Services Co. and as an Independent Director at FTE Networks, Inc. He obtained an undergraduate degree from Rutgers State University of New Jersey and an MBA from Pepperdine University.

Barbara Rothman has a current job as a Trustee at Children's Specialized Hospital.

Paul B.
Rothman is currently an Independent Director at Laboratory Corp.
of America Holdings and Merck & Co., Inc. He is also a Director at Merck Sharp & Dohme Corp., King Faisal Specialist Hospital & Research Centre, MSD Pharma (Singapore) Pte Ltd., and the Center for Medical Interoperability.
Additionally, he serves as an Independent Director at Labcorp Holdings, Inc. and as an Ex-Officio Trustee at The Johns Hopkins Hospital, Inc. He previously held the position of Vice President-Medicine at The Johns Hopkins University and was the Chief Executive Officer of Johns Hopkins Medicine, Inc. from 2012 to 2022.
He also served as the Dean of the University of Iowa Carver College of Medicine from 2008 to 2012.
Dr. Rothman is a Member of various prestigious organizations including the American Academy of Arts & Sciences, the American Association for the Advancement of Science, the National Academy of Medicine (United States), the Association of American Physicians, and the American Society for Clinical Investigation.
He has also served as a Trustee for Johns Hopkins Community Physicians, Inc. Dr. Rothman completed his undergraduate studies at the Massachusetts Institute of Technology and obtained his doctorate degree from Yale University.

Simon Rothman was the founder of eBay Motors, where he held the title of Global Vice President & General Manager.
eBay Motors was founded in 1999.
Mr. Rothman is also the founder of Glyde Corp.
Mr. Rothman's current job(s) include being a Director at EatWith Media Ltd.
since 2014, a Director at Ritual Technologies, Inc., a Director at Nuro, Inc. since 2017, and a Venture Partner at Greylock Management Corp.
since 2011.
Mr. Rothman's former job(s) include being a Director at Tesla, Inc., Cargurus, Inc., Sprig, Inc., Convoy, Inc. (United States), and GE Aerospace.
He also served as an Advisor at TangoMe, Inc., Lyft, Inc., Poshmark, Inc., and Wanelo, Inc.Mr. Rothman's education history includes undergraduate and MBA degrees from Harvard University.

Mr. Aidan-John Rothman is Chief Executive Officer & Executive Director at RBA Holdings Ltd.
He is on the Board of Directors at RBA Holdings Ltd.
He received his undergraduate degree from the University of the Witwatersrand and an MBA from the University of the Witwatersrand.

Ronald K.
Rothman is currently a Director at Vindicator Technologies, Inc. He was previously a Senior Vice President-Sales & Business Development at AFA Protective Systems, Inc.

Alexander Rothman is currently working as a Director at SMS Assist LLC.
He completed his undergraduate degree at Boston University.

Robert Rothman is the founder and founding partner & principal of Infocus Capital Partners since 2016.
He is currently the Director of Ophthalmology Strategic Initiatives at Northwell Health, Inc. since 2017.
He is also a Director at Alievio, Inc., Qura, Inc., and Cellview Imaging, Inc. Additionally, he is the Director of Northwell Health Garden City Surgicenter since 2010 and a Director at Alliedmedix Resources Inc. Furthermore, he is a Partner at Glaucoma Consultants Long Island since 2000.

Howard J.
Rothman is currently the Secretary & Director at Alliance for Young Artists & Writers, Inc. He was previously the Vice Chairman at New York Foundation for the Arts.

Prior to joining ISI in February 2005, Mr. Rothman was the co-global coordinator for the Merrill Lynch energy team, which was ranked #1 in the Global Research Survey by Institutional Investor magazine in 2004.
Mr. Rothman graduated from Rutgers University in 1982 and received his MS from Rutgers in 1984.

Noel N.
Rothman is currently the President of Namtor, Inc. since 1985.
He was formerly the Director of CoBiz Financial, Inc. from 1994 to 2011.

John M.
Rothman is currently the Executive Vice President-Product Development at Tyme Technologies, Inc. He previously worked as the EVP-Clinical & Scientific Operations at Advaxis, Inc. from 2011 to 2013.
He also worked as the Chief Scientific Officer at Race Oncology Ltd.
Dr. Rothman earned a doctorate degree from Tulane University School of Medicine.

Richard Rothman is the founder of Total Executive Wellness, which was founded in 2011.
He held the title of President from 2011 to 2017.
Currently, he is the Head-Performance & Engagement at GLP Pte.
Ltd.
since 2018.
Mr. Rothman has an MBA degree from Drexel University, which he received in 2000.
He also has an undergraduate degree from the University of Colorado Boulder, which he received in 1991.

Matthew A.
Rothman is currently the Secretary & General Counsel at Aclaris Therapeutics, Inc. He previously worked as an Associate at Dechert LLP from 2012 to 2018.
He completed his undergraduate degree at the University of Pittsburgh and his graduate degree at The University of Pennsylvania Law School.

Thomas E.
Rothman was the founder of Searchlight Pictures, Inc. (founded in 1994) where he served as President.
He is currently the Chairman & CEO-Motion Picture Group at Sony Pictures Entertainment, Inc. (since 2015) and an Independent Director at Booking Holdings, Inc. (since 2013).
He also holds positions as Director-Emeritus at Brown University, Director at California Institute of the Arts, Director-Emeritus at American Film Institute, Inc., and Member-Governing Board at National Endowment for the Arts (all current positions).
In his former roles, Mr. Rothman was the Chief Executive Officer of Fox Entertainment Group, Inc. (2005-2012), Co-Chairman & Co-Chief Executive Officer of Fox Filmed Entertainment, Inc. (2000-2012), Chairman of Tristar Productions, Inc. (2013-2015), President-Worldwide Production at Samuel Goldwyn Co. (1994), President of 20th Century Studios (2000), President of Fox Productions, Inc. (1995-2000), and Partner at Frankfurt, Kurnit, Klein & Selz PC (1982-1987).
He also served as a Trustee Emeritus at The Sundance Institute and was a Member of the National Council on the Arts.
Mr. Rothman completed his undergraduate studies at Brown University and obtained a graduate degree from Columbia Law School.

Robert E.
Rothman is currently the President of Gap International, Inc. since 1987.
He completed his undergraduate degree from The Ohio University.

Mr. Jacob Rothman is a Senior Advisor at Beach Point Capital Management LP.
He focuses on opportunistic credit mandates.
Mr. Rothman has been investing in distressed and private equity since 1998.
Prior to Beach Point he was a Principal at Watershed Asset Management focusing on distressed investments.
He was previously a Portfolio Manager at Canvas Capital.
Mr. Rothman also worked at Kohlberg Kravis Roberts & Co. on private equity transactions and Morgan Stanley in the corporate finance and Mergers and Acquisitions groups.
Mr. Rothman received a Bachelor’s degree in Economics with a minor in Accounting from the University of California, Los Angeles.

Jake Rothman is the founder of Rothman Investment Management LLC.
Prior to founding his own company, he worked as an Analyst at Colrain Capital LLC and as a Vice President & Analyst at Madison Asset Management LLC.
Before entering the finance industry, he served as the Chief Financial Officer at Albany Area Primary Health Care, Inc. Rothman holds an MBA from the University of Virginia and an undergraduate degree from the University of California San Diego.

Mr. Andy Rothman is an Investment Strategist at Matthews International Capital Management LLC.
He is responsible for research on China’s economy and on U.S.-China relations.
Prior to joining Matthews Asia in 2014, Mr. Rothman spent 14 years as CLSA’s China macroeconomic strategist where he conducted analysis into China and delivered his insights to their clients.
Previously, he spent 17 years in the U.S.
Foreign Service, with a diplomatic career focused on China, including as head of the macroeconomics and domestic policy office of the U.S.
embassy in Beijing.
Mr. Rothman received his B.A.
degree from Colgate University and an M.A.
in public administration from Lyndon B Johnson School of Public Affairs.

Steven I.
Rothman is the founder of PeraHealth, Inc. (founded in 2005).
He was also a former Chairman of Zavanna LLC, a former Principal of Bravo Resources Ltd., and a former Principal of The MITRE Corp.
Rothman received a graduate degree from Northeastern University in 1972 and an undergraduate degree from Rensselaer Polytechnic Institute in 1969.

Richard Rothman has a current job as Co-Chairman at Graham Windham.

Josh Rothman is currently the CEO at Otherleft Ventures LLC, Director at PointClear Solutions, Inc., and Manager at MEDHOST, Inc. He previously worked as Vice President at Episode Solutions LLC from 2018 to 2019.
He received his undergraduate degree from Tennessee Technological University in 1998.